Thyroid Problems in Children: Signs & Functional Approach
Quick Answer
Thyroid disorders in children — including congenital hypothyroidism, Hashimoto’s thyroiditis, and Graves’ disease — can impair growth, neurodevelopment, and emotional regulation. Thyroid-stimulating hormone (TSH) and free thyroxine (free T4) testing may identify dysfunction early. Standard medical treatment remains essential, while supportive functional medicine strategies addressing nutrient status, gut health, and stress management may complement conventional care.
You can learn more about how comprehensive thyroid assessment is approached in clinical practice on our thyroid health page.
At a Glance
- Thyroid hormones (T3 and T4) are essential regulators of brain myelination, linear growth, and metabolic rate in children
- Congenital hypothyroidism affects approximately 1 in 2,000-4,000 newborns and is detected through routine newborn screening in Australia
- Hashimoto’s thyroiditis is the most common cause of acquired hypothyroidism in children, driven by anti-thyroid peroxidase (anti-TPO) antibodies
- Graves’ disease accounts for the majority of paediatric hyperthyroidism cases, with TSH receptor antibody (TRAb) involvement
- Iodine, selenium, and zinc are key micronutrients associated with healthy thyroid hormone synthesis and conversion
- Early diagnosis and intervention may reduce the risk of irreversible neurodevelopmental and growth-related complications
What Does the Thyroid Gland Do?
The thyroid gland produces triiodothyronine (T3) and thyroxine (T4), hormones that regulate basal metabolic rate, thermogenesis, and cellular energy production throughout the body. Located at the base of the neck in a butterfly shape, this small endocrine organ plays an outsized role during childhood. Adequate thyroid hormone levels are critical for central nervous system myelination, linear bone growth, pubertal timing, and hypothalamic-pituitary-thyroid (HPT) axis regulation. When thyroid hormone production is insufficient or excessive, a wide range of developmental and behavioural concerns can emerge, as documented by Williams (2008) in the Journal of Neuroendocrinology.
Common Thyroid Disorders in Children
1. Hypothyroidism (Underactive Thyroid)
Hypothyroidism, characterised by insufficient thyroid hormone output, is the most prevalent thyroid disorder in the paediatric population. It may be present from birth (congenital hypothyroidism, affecting approximately 1 in 2,000-4,000 newborns according to LaFranchi, 1999) or develop later in childhood as acquired hypothyroidism. Common features include:
| Symptom | Clinical Significance |
|---|---|
| Slower growth or reduced height velocity | May indicate growth hormone and thyroid axis disruption |
| Fatigue and excessive sleepiness | Associated with reduced basal metabolic rate |
| Constipation | Reflects slowed gastrointestinal motility |
| Dry skin and brittle hair | Linked to reduced dermal perfusion and keratin metabolism |
| Poor concentration or school performance | May reflect impaired neurocognitive function |
| Mood changes (low mood, irritability) | Associated with altered serotonin and dopamine signalling |
| Delayed puberty | Reflects HPT axis influence on gonadotropin release |
Congenital hypothyroidism is particularly important to identify early, as thyroid hormone is essential for normal brain development in infancy. As documented by Fisher (1997) in the Endocrine Reviews, inadequate T4 levels during the neonatal period can lead to irreversible neurodevelopmental impairment. In Australia, the National Newborn Screening Programme routinely tests for this condition shortly after birth via heel-prick blood sampling. If hypothyroidism develops later, symptoms may be more subtle and progress gradually, as noted by Chaker et al. (2017) in The Lancet.
2. Hyperthyroidism (Overactive Thyroid)
Hyperthyroidism, characterised by excessive circulating thyroid hormone, is less common than hypothyroidism in children but can present with significant clinical features. Rivkees (2014) documented the following presentations in the paediatric population:
| Symptom | Underlying Mechanism |
|---|---|
| Rapid heartbeat or palpitations | Excess T3 increases cardiac beta-adrenergic receptor sensitivity |
| Unintentional weight loss | Elevated metabolic rate despite normal caloric intake |
| Anxiety, restlessness, nervousness | Central nervous system overstimulation |
| Tremors | Increased neuromuscular excitability |
| Difficulty sleeping | Sympathetic nervous system activation |
| Heat intolerance and sweating | Increased thermogenesis and peripheral vasodilation |
In Graves’ disease — the most common cause of paediatric hyperthyroidism — TSH receptor antibodies (TRAb) stimulate the thyroid to overproduce hormones, and Graves’ ophthalmopathy (eye changes) may also occur. While hyperthyroidism can initially accelerate growth, prolonged exposure to excess hormone may lead to premature epiphyseal closure of growth plates, as described by Garbe et al. (2011) in Hormone Research in Paediatrics.
3. Autoimmune Thyroid Disease
Autoimmune thyroid conditions, including Hashimoto’s thyroiditis and Graves’ disease, are increasingly recognised in children and adolescents, as reviewed by Brown (2009) in the Journal of Clinical Endocrinology and Metabolism. These disorders arise when the immune system produces antibodies — anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) in Hashimoto’s, or TRAb in Graves’ — that target thyroid tissue, altering hormone production over time. A family history of autoimmune disease, human leukocyte antigen (HLA) polymorphisms, and environmental triggers can increase risk. Wiersinga (2014) noted that immune regulation through the T-helper cell (Th1/Th2) balance is an important consideration in ongoing management.
How Are Thyroid Disorders Diagnosed?
Comprehensive thyroid evaluation typically includes measurement of TSH, free T4, and in some cases free T3 to assess peripheral hormone conversion. Evaluation usually begins with these blood tests, as recommended by the American Academy of Pediatrics (AAP) and the Endocrine Society. Thyroid antibody testing — including anti-TPO, anti-Tg, and TRAb — is used to assess for autoimmune involvement. Thyroid ultrasound may be recommended if there is thyroid enlargement (goitre) or concern about structural changes such as nodules.
Early diagnosis is important, as untreated thyroid dysfunction in children can contribute to learning difficulties, delayed growth, and other long-term complications. A detailed interpretation of thyroid markers — including the TSH-to-free T4 ratio and antibody trends over time — rather than relying on a single value can be clinically important, which is a principle discussed further in our overview of integrated thyroid assessment.
How a Supportive Functional Medicine Approach May Help
Conventional medical management, including levothyroxine replacement for hypothyroidism or antithyroid medications (methimazole/carbimazole) for hyperthyroidism, remains the foundation of care for paediatric thyroid disorders. A functional medicine approach does not replace this care but may be used alongside it to explore modifiable factors that can influence overall health and immune balance.
| Supportive Strategy | Relevance to Thyroid Health |
|---|---|
| Iodine status assessment | Iodine is the essential substrate for T3 and T4 synthesis; deficiency remains a global concern (Zimmermann, 2009) |
| Selenium adequacy | Required for glutathione peroxidase and deiodinase enzyme activity; may support thyroid antioxidant defence (Ventura et al., 2017) |
| Zinc status | Cofactor for thyroid hormone receptor binding and TSH signalling |
| Digestive health support | Optimises micronutrient absorption and may influence immune tolerance |
| Chronic stressor identification | Cortisol dysregulation may impair HPT axis function and T4-to-T3 conversion |
| Environmental burden reduction | Endocrine-disrupting chemicals (EDCs) may interfere with thyroid receptor activity |
Gut and Immune Support
Approximately 70% of the body’s immune tissue resides in the gut-associated lymphoid tissue (GALT), making gastrointestinal health a relevant consideration in autoimmune thyroid conditions. While gut-focused strategies are not treatments for thyroid disease itself, maintaining intestinal barrier integrity and microbiome diversity may support overall immune resilience, particularly in Hashimoto’s thyroiditis where molecular mimicry and intestinal permeability have been studied. This broader immune-gut relationship is explored in more detail in our educational resource on the gut microbiome.
Stress and Sleep Support
Chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis and poor sleep can influence thyroid hormone signalling, cortisol-mediated suppression of TSH, and immune function. Age-appropriate stress management strategies, consistent circadian routines, and adequate sleep duration (as recommended by the Australasian Sleep Association) are important foundations for supporting children living with chronic health conditions, including thyroid disorders.
Next Steps
- Monitor for signs: Watch for persistent symptoms such as slowed growth, fatigue, learning difficulties, unexplained weight changes, or signs of early or delayed puberty in your child.
- Seek comprehensive assessment: If thyroid concerns are suspected, request testing that includes TSH, free T4, free T3, and thyroid antibodies (anti-TPO, anti-Tg) rather than relying on a single marker.
- Consider supportive strategies: Alongside standard medical care, optimising nutrition (iodine, selenium, zinc), gut health, and stress management may support your child’s overall resilience and thyroid health.
Frequently Asked Questions
Key Insights
- Thyroid hormones (T3 and T4) are essential for normal growth, brain myelination, and neurodevelopment in children
- Both hypothyroidism and hyperthyroidism can present with subtle, non-specific symptoms that may mimic other paediatric conditions
- Autoimmune thyroid disease (Hashimoto’s thyroiditis, Graves’ disease) is increasingly recognised in children and adolescents
- Medical diagnosis and treatment — including levothyroxine and antithyroid medications — are central to care, with supportive strategies used only as adjuncts
- Early assessment and monitoring of TSH, free T4, and thyroid antibodies are critical for long-term health outcomes
Citable Takeaways
- Congenital hypothyroidism affects approximately 1 in 2,000-4,000 newborns and is routinely screened for via the Australian National Newborn Screening Programme (LaFranchi, Thyroid, 1999).
- Hashimoto’s thyroiditis, characterised by anti-TPO and anti-Tg antibodies, is the leading cause of acquired hypothyroidism in children and adolescents (Brown, J Clin Endocrinol Metab, 2009).
- Selenium is a required cofactor for deiodinase enzymes responsible for T4-to-T3 conversion, and supplementation may support thyroid antioxidant defence in autoimmune thyroiditis (Ventura et al., Int J Endocrinol, 2017).
- Iodine deficiency remains a significant global contributor to thyroid dysfunction, affecting an estimated 2 billion people worldwide (Zimmermann, Endocr Rev, 2009).
- Thyroid hormone timing during early development is critical for brain myelination and neurocognitive outcomes, with inadequate levels potentially leading to irreversible impairment (Zoeller and Rovet, Endocrinology, 2004).
- Graves’ disease, driven by TSH receptor antibodies (TRAb), accounts for the majority of paediatric hyperthyroidism cases and may require long-term antithyroid therapy (Rivkees, Int J Pediatr Endocrinol, 2014).
Supporting Your Child’s Thyroid Health
If you are concerned about your child’s growth, energy, learning, or emotional wellbeing, timely medical assessment is essential. For families interested in a collaborative, integrative approach that works alongside standard paediatric care, Elemental Health and Nutrition offers personalised support focused on nutrition, immune balance, and overall resilience.
References
- Fisher DA. Disorders of the thyroid in the newborn and infant. Endocr Rev. 1997 Apr;18(2):229-60. https://doi.org/10.1210/edrv.18.2.0298
- American Academy of Pediatrics Newborn Screening Authoring Committee. Newborn screening fact sheets. Pediatrics. 2006 Sep;118(3):e934-63. https://doi.org/10.1542/peds.2006-1783
- LaFranchi SH. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid. 1999 Jul;9(7):735-40. https://doi.org/10.1089/thy.1999.9.735
- Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: evidence from rodents and humans. Endocrinology. 2004 Jul;145(7):2739-45. https://doi.org/10.1210/en.2004-0223
- De Groot L et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65. https://doi.org/10.1210/jc.2011-2803
- Brown RS. Autoimmune thyroid disease in children and adolescents. J Clin Endocrinol Metab. 2009 Sep;94(9):3175-85. https://doi.org/10.1210/jc.2009-0730
- Rivkees SA. Pediatric Graves’ disease: management in the post-propylthiouracil era. Int J Pediatr Endocrinol. 2014;2014(1):10. https://doi.org/10.1186/1687-9856-2014-10
- Garbe E et al. Hyperthyroidism in children and adolescents: a review. Horm Res Paediatr. 2011;75(1):1-8. https://doi.org/10.1159/000321370
- Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39-51. https://doi.org/10.1093/bmb/ldr033
- Zimmermann MB. Iodine deficiency. Endocr Rev. 2009 Jun;30(4):376-408. https://doi.org/10.1210/er.2009-0011
- Ventura M et al. Selenium and thyroid disease: from pathophysiology to treatment. Int J Endocrinol. 2017;2017:1297658. https://doi.org/10.1155/2017/1297658
- Gaitonde DY et al. Hypothyroidism: an update. Am Fam Physician. 2012 Aug 1;86(3):244-51. https://pubmed.ncbi.nlm.nih.gov/22963093/
- Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 2008 Jun;20(6):784-94. https://doi.org/10.1111/j.1365-2826.2008.01733.x
- Wiersinga WM. Thyroid autoimmunity. Endocr Dev. 2014;26:139-57. https://doi.org/10.1159/000363163
- Chaker L et al. Hypothyroidism. Lancet. 2017 Aug 26;390(10101):1550-62. https://doi.org/10.1016/S0140-6736(17)30703-1
